Trial Profile
Pharmacokinetics study of piperacillin-tazobactam and meropenem in obese patients
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 22 Jul 2017
Price :
$35
*
At a glance
- Drugs Meropenem (Primary) ; Piperacillin/tazobactam (Primary)
- Indications Obesity
- Focus Pharmacokinetics
- 30 Sep 2014 New trial record